Beta2-glycoprotein I in thrombosis: Evidence for a role as a natural anticoagulant

British Journal of Haematology

Volumn 93, Issue 1, 1996, Pages 185-194

  Brighton, T A ^a   Hogg, P J ^a   Dai, Y P ^a   Murray, B H ^a   Chong, B H ^a   Chesterman, C N ^a,b  

^a UNIVERSITY OF NEW SOUTH WALES   (Australia)

^b PRINCE OF WALES HOSPITAL   (Australia)

Author keywords

acute phase reactant; anticardiolipin antibodies; anticoagulant; beta2 glycoprotein I; thrombosis

Indexed keywords

ACUTE PHASE PROTEIN; BETA2 GLYCOPROTEIN 1; BLOOD CLOTTING INHIBITOR; CARDIOLIPIN ANTIBODY;

ARTICLE; CONTROLLED STUDY; DISSEMINATED INTRAVASCULAR CLOTTING; HUMAN; MAJOR CLINICAL STUDY; PRIORITY JOURNAL; THROMBOSIS;

ACUTE DISEASE; ANTITHROMBIN III; APOLIPOPROTEINS; BETA 2-GLYCOPROTEIN I; BLOOD COAGULATION; DISSEMINATED INTRAVASCULAR COAGULATION; GLYCOPROTEINS; HUMANS; PROTEIN C; THROMBOSIS;

EID: 0030007187     PISSN: 00071048     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2141.1996.446981.x     Document Type: Article

References (36)

1. Bansci, L.F., van der Linden, I.K. & Bertina, R.M. (1992) Beta 2-glycoprotein I deficiency and the risk of thrombosis. Thrombosis and Haemostasis, 67, 649-653.
2. Blackburn, H., Keys, A., Simpson, E., Rautaharju, P. & Punsar, S. (1966) The electrocardiogram in population studies: a classification system. Circulation, 21, 1160-1175.
3. Bovill, E.G., Bauer, K.A., Dickerman, J.D., Callas, P. & West, B. (1989) The clinical spectrum of heterozygous protein C deficiency in a large New England kindred. Blood, 73, 712-717.
4. Brighton, T.A. & Chesterman, C.N. (1994) Antiphospholipid antibodies and thrombosis. Bailliere's Clinical Haematology, 7(3), 541-557.
5. Chong, B.H. (1992) Heparin-induced thrombocytopenia. Australian and New Zealand Journal of Medicine, 22, 145-152.
6. Fleck, A. (1985) Computer models for metabolic studies on plasma proteins. Annals of Clinical Biochemistry, 22, 33-49.
7. Fleck, A., Hawker, F., Wallace, P.I., Raines, G., Trotters, J. & Ledingham, I.M. (1985) Increased vascular permeability: a major cause of hypoalbuminaemia in disease and injury. Lancet, i, 781-783.
8. Galli, M., Comfurius, P., Maassen, C., Hemker, H.C., de Baets, M.H., vanBreda-Vriesman, P.J., Barbui, T., Zwaal, R.F. & Bevers, E.M. (1990) Anticardiolipin antibodies (ACA) directed not to cardiolipin but to a plasma protein cofactor. Lancet, 335, 1544-1547.
9. Hunt, J.E., McNeil, H.P., Morgan, G.J., Crameri, R.M & Krills, S.A. (1992) A phospholipid-beta 2-glycoprotein I complex is an antigen for anticardiolipin antibodies occurring in autoimmune disease but not with infection. Lupus, 1, 75-81.
10. Hunt, J.E., Simpson, R.J. & Krills, S.A. (1993) Identification of a region of beta 2-glycoprotein I critical for lipid binding and anticardiolipin antibody cofactor activity. Proceedings of the National Academy of Sciences of the United States of America, 90, 2141-2145.
11. Liang, K.Y. & Zeger, S.L. (1986) Longitudinal data anaysis using generalised linear models. Biometrika, 73, 13-22.
12. Love, K.Y. & Zeger, S.L. (1990) Antiphospholipid antibodies: anticardiolipin and the lupus anticoagulant in systemic lupus erythematosus (SLE) and in non-SLE disorders: prevalence and clinical significance. Annals of Internal Medicine, 112, 682-698.
13. Lozier, J., Takahashi, N. & Putnam, F.W. (1984) Complete amino acid sequence of human plasma beta 2-glycoprotein. Proceedings of the National Academy of Sciences of the United States of America, 81, 3640-3644.
14. Matsuda, J., Wakasugi, K., Saitoh, N., Tsukamoto, M., Miyajima, Y., Kazama, M.A. & Hashimoto, M. (1993) Low beta 2-glycoprotein I levels in patients with disseminated intravascular coagulation. American Journal of Hematology, 42, 234-235.
15. McNeil, H.P., Chesterman, C.N. & Krilis, S.A. (1991) Immunology and clinical importance of antiphospholipid antibodies. Advances in Immunology, 49, 193-280.
16. McNeil, H.P., Simpson, R.J., Chesterman, C.N. & Krilis, S.A. (1990) Antiphospholipid antibodies are directed against a complex antigen that includes a lipid-binding inhibitor of coagulation: bega 2-glycoprotein I (apolipoprotein H). Proceedings of the National Academy of Sciences of the United States of America, 87, 4120-4124.
17. Mehdi, H., Nunn, M., Steel, D.M., Whitehead, A.S., Perez, M., Walker, L. & Peeples, M.E. (1991) Nucleotide sequence and expression of the human gene encoding apolipoprotein H (beta 2-glycoprotein I). Gene, 108, 293-298.
18. Miletich, J., Shearman, L. & Broze, G. (1987) Absence of thrombosis in subjects with heterozygous protein C deficiency. New England Journal of Medicine, 317, 649-653.
19. Nielsen, O.M., Thunedborg, P. & Jorgensen, K. (1989) Albumin administration and acute phase proteins in abdominal vascular surgery. Danish Medical Bulletin, 36, 496-499.
20. Nimpf, J., Wurm, H. & Kostner, G.M. (1985) Interaction of beta 2-glycoprotein-I with human blood platelets: influence upon the ADP-induced aggregation. Thrombosis and Haemostasis, 54, 397-401.
21. Nimpf, J., Bevers, E.M., Bomans, P.H., Till, U., Wurm, H., Kostner, G.M. & Zwaal, R.F. (1986) Prothrombinase activity of human platelets is inhibited by beta 2-glycoprotein-I. Biochimica et Biophysica Acta, 884, 142-149.
22. Nomura, S., Fukuhara, S., Komiyama, Y., Takahashi, H., Matsuura, E., Nagakaki, T., Funatsu, A., Sugo, T., Matsuda, M. & Koike, T. (1994) Beta 2-glycoprotein I and anticardiolipin antibody influence factor Xa generation but not factor Xa binding to platelet-derived microparticles. Thrombosis and Haemostasis, 71, 526-527.
23. Nomura, S., Komiyama, Y., Matsuura, E., Kokawa, T., Takahashi, H. & Koike, T. (1993) Binding of beta 2-glycoprotein I to platelet derived microparticles. Kritish Journal of Haematology, 85, 639-640.
24. Polz, E. & Kostner, G.M. (1979) The binding of beta 2-glycoprotein-I to human serum lipoproteins: distribution among density fractions. FEBS Letters, 102, 183-186.
25. Propert, D.N. (1978) The relation of sex, smoking status, birth rank, and parental age to B2-glycoprotein I levels and phenotypes in a sample of Australian Caucasian adults. Human Genetics, 43, 281-288.
26. Rodbard, D. (1974) Statistical quality control and routine data processing for radioimmunoassays and immunoradiometric assays. Clinical Chemistry, 20, 1255-1270.
27. Schousboe, I. (1980) Binding of beta 2-glycoprolein I to platelets: effect of adenylate cyclase activity. Thrombosis Research, 19, 225-237.
28. Schousboe, I. (1985) Beta 2-glycoprotein I: a plasma inhibitor of the contact activation of the intrinsic blood coagulation pathway. Blood, 66, 1086-1091.
29. Schultze, H.E., Heide, K. & Haupt, H. (1961) Uber ein bisher unbekanntes Niedermolekulares B2-Globulin des Humanserums. Naturwissenschaften, 23, 719.
30. Shi, W., Chong, B.H. & Chesterman, C.N. (1995a) Beta 2-glycoprotein I is a requirement for anticardiolipin antibodies binding to activated platelets: differences with lupus anti-coagulants. Blood, 81, 1255-1262.
31. Shi, W., Chong, B.H., Hogg, P.J. & Chesterman, C.N. (1993b) Anticardiolipin antibodies block the inhibition by beta 2-glycoprotein I of the factor Xa generating activity of platelets. Thrombosis and Haemostasis, 70, 342-345.
32. Steinkasserer, A., Barlow, P.N., Willis, A.C., Kertesz, Z., Campbell, I.D., Sim, R.B. & Norman, D.G. (1992) Activity, disulphide mapping and structural modelling of the fifth domain of human beta 2-glycoprotein I. FEBS Letters, 313, 195-197.
33. Tabernero, M.D., Tomas, J.F., Alberca, I., Orfao, A., Borrasca, A.L. & Vicente, V. (1991) Incidence and clinical characteristics of hereditary disorders associated with venous thrombosis. American Journal of Hematology, 36, 249-254.
34. Triplett, D.A. (1992) Antiphospholipid antibodies: proposed mechanisms of action. American Journal of Reproductive Immunology, 28, 211-215.
35. Vaitukaitis, J., Robbins, J.B., Nieschlag, E. & Ross, G.T. (1971) A method for producing specific antisera with small doses of immunogen. Journal of Clinical Endocrinology and Metabolism, 33, 988-991.
36. Wurm, H. (1984) Beta 2-glycoprotein-I (apolipoprotein H) interactions with phospholipid vesicles. International Journal of Biochemistry, 16, 511-515.